Synthaverse S.A.

DB:6NQ Stock Report

Market Cap: €73.2m

Synthaverse Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Mieczyslaw Starkowicz

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.1yrs
CEO ownership0.2%
Management average tenureno data
Board average tenure3.1yrs

Recent management updates

Recent updates

CEO

Mieczyslaw Starkowicz

2.1yrs

Tenure

Mr. Mieczyslaw Starkowicz serves as President of the Management Board and Chief Executive Officer at Synthaverse S.A. (formerly known as BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.) since August 202...

Board Members

NamePositionTenureCompensationOwnership
Waldemar Sierocki
Secretary of Supervisory Board & Member of Supervisory Boardno datazł24.00k6.48%
PLN 4.7m
Konrad Miterski
Member of the Supervisory Boardno datazł42.00k0.072%
PLN 52.8k
Wiktor Napióra
Vice Chairman of the Supervisory Boardno datazł40.00k7.2%
PLN 5.3m
Dariusz Kucowicz
Member of Supervisory Board16.7yrszł39.00k0.31%
PLN 223.6k
Maciej Korniluk
Member of Supervisory Board1.7yrsno datano data
Jaroslaw Blaszczak
Chairman of the Supervisory Boardno datazł113.00k2%
PLN 1.5m
Dirk Pamperin
Member of the Supervisory Board4.6yrszł37.00kno data
Maciej Siedlar
Member of Supervisory Board1.7yrsno data0.14%
PLN 104.4k

3.1yrs

Average Tenure

Experienced Board: 6NQ's board of directors are considered experienced (3.1 years average tenure).